Surgical management of giant pediatric craniopharyngiomas
- PMID: 21039162
- DOI: 10.3171/2010.8.PEDS09385
Surgical management of giant pediatric craniopharyngiomas
Abstract
Object: Prior work by the authors' group and reports of other authors suggest worse functional outcomes and decreased survival in children with larger craniopharyngiomas. The purpose of this study was to assess the oncological, endocrinological, and functional outcomes in children who underwent radical resection of giant craniopharyngiomas (defined as 5 cm or greater in largest diameter).
Methods: Between 1986 and 2006, 26 children under the age of 18 (14 boys, 12 girls; mean age 10.5 years) underwent radical resection of giant craniopharyngiomas performed by the senior author. Data were retrospectively collected to assess the outcome of surgical treatment.
Results: Twenty (77%) of 26 patients underwent gross-total resection (GTR) confirmed by intraoperative inspection and postoperative imaging. All primary tumors (17 of 17) and 3 (33%) of 9 recurrent tumors were treated with GTR. There was no operative mortality, and 18 of 26 patients (69%) were alive at a mean follow-up of 8.9 years (median 9.3 years). Disease control was achieved in 21 (84%) of the 25 patients followed up for more than 6 months and was more successful in patients who underwent GTR (95%) than in those who underwent STR (50%, p = 0.03). New-onset diabetes insipidus (DI) occurred in 63.2% of patients (73% of patients had DI postoperatively). New or worsened deficits in visual acuity and visual fields occurred in 16% and 28%, respectively, of the 25 patients for whom postoperative visual data were available. Five patients (19%) experienced significant, permanent neurological deficits, and 5 (19%) had mild to moderate deficits. New or worsened hypothalamic disturbance occurred in 35% and 22% of patients, respectively, but obesity developed in only 15%.
Conclusions: In this retrospective series, radical resection of giant craniopharyngiomas in children was found to lead to excellent rates of disease control with acceptable or good functional outcomes but slightly higher rates of neurological complications compared with rates in patients with smaller tumors. Radical resection is less successful in recurrent tumors that reach very large sizes, especially previously irradiated tumors, with resultant diminished survival.
Comment in
-
Less is less.J Neurosurg Pediatr. 2010 Nov;6(5):401-2; discussion 402. doi: 10.3171/2009.12.PEDS09508. J Neurosurg Pediatr. 2010. PMID: 21039161 No abstract available.
Similar articles
-
Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children.J Neurosurg Pediatr. 2010 Jan;5(1):30-48. doi: 10.3171/2009.7.PEDS09215. J Neurosurg Pediatr. 2010. PMID: 20043735
-
The transsphenoidal resection of pediatric craniopharyngiomas: a case series.J Neurosurg Pediatr. 2010 Jan;5(1):49-60. doi: 10.3171/2009.7.PEDS09252. J Neurosurg Pediatr. 2010. PMID: 20043736
-
Successful surgical treatment of craniopharyngioma in very young children.J Neurosurg Pediatr. 2009 May;3(5):397-406. doi: 10.3171/2009.1.PEDS08401. J Neurosurg Pediatr. 2009. PMID: 19409019
-
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409. doi: 10.1111/j.1365-2265.2005.02231.x. Clin Endocrinol (Oxf). 2005. PMID: 15807869 Review.
-
Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.J Neurosurg. 2007 Jan;106(1 Suppl):3-12. doi: 10.3171/ped.2007.106.1.3. J Neurosurg. 2007. PMID: 17233305 Review.
Cited by
-
Giant craniopharyngiomas in children: short- and long-term implications.Childs Nerv Syst. 2016 Jan;32(1):79-88. doi: 10.1007/s00381-015-2961-6. Epub 2015 Nov 16. Childs Nerv Syst. 2016. PMID: 26572512
-
Radiotherapy alone for pediatric patients with craniopharyngioma.J Neurooncol. 2022 Jan;156(1):195-204. doi: 10.1007/s11060-021-03908-2. Epub 2021 Nov 30. J Neurooncol. 2022. PMID: 34846639
-
Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.Neuro Oncol. 2013 Jun;15(6):767-74. doi: 10.1093/neuonc/not026. Epub 2013 Mar 13. Neuro Oncol. 2013. PMID: 23486689 Free PMC article. Clinical Trial.
-
Risk-adapted, long-term management in childhood-onset craniopharyngioma.Pituitary. 2017 Apr;20(2):267-281. doi: 10.1007/s11102-016-0751-0. Pituitary. 2017. PMID: 27604996 Review.
-
Pituitary stalk management during the microsurgery of craniopharyngiomas.Exp Ther Med. 2014 May;7(5):1055-1064. doi: 10.3892/etm.2014.1561. Epub 2014 Feb 19. Exp Ther Med. 2014. PMID: 24940387 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical